unknown
Stage
1
Investors
About
Aurigen Medical develops the Zenith left atrial appendage occlusion (LAAO) medical device to treat patients with atrial fibrillation. The company has reported completion of a first-in-human implantation at Auckland City Hospital as part of its clinical validation.
Explore Aurigen Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.